Topspin Fund L.P. 4

Accession 0001209191-20-025989

CIK 0001796280other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:11 PM ET

Size

24.7 KB

Accession

0001209191-20-025989

Form 4

Period: 2020-04-28

10% Owner

Transactions

Conversion
Common Stock
2020-04-28+231,250→ 231,250 total
Conversion
Series C Preferred Stock
2020-04-28−497,809→ 0 total
→ Common Stock (497,809 underlying)
Conversion
Series D Preferred Stock
2020-04-28−314,815→ 0 total
→ Common Stock (314,815 underlying)
Conversion
Series B Preferred Stock
2020-04-28−2,268,750→ 0 total(indirect: See footnote)
→ Common Stock (2,268,750 underlying)
Conversion
Common Stock
2020-04-28+2,268,750→ 2,268,750 total(indirect: See footnote)
Conversion
Common Stock
2020-04-28+314,815→ 1,043,874 total
Conversion
Series B Preferred Stock
2020-04-28−231,250→ 0 total
→ Common Stock (231,250 underlying)
Conversion
Common Stock
2020-04-28+497,809→ 729,059 total

10% Owner

Transactions

Conversion
Common Stock
2020-04-28+314,815→ 1,043,874 total
Conversion
Series B Preferred Stock
2020-04-28−231,250→ 0 total
→ Common Stock (231,250 underlying)
Conversion
Series B Preferred Stock
2020-04-28−2,268,750→ 0 total(indirect: See footnote)
→ Common Stock (2,268,750 underlying)
Conversion
Series C Preferred Stock
2020-04-28−497,809→ 0 total
→ Common Stock (497,809 underlying)
Conversion
Series D Preferred Stock
2020-04-28−314,815→ 0 total
→ Common Stock (314,815 underlying)
Conversion
Common Stock
2020-04-28+497,809→ 729,059 total
Conversion
Common Stock
2020-04-28+2,268,750→ 2,268,750 total(indirect: See footnote)
Conversion
Common Stock
2020-04-28+231,250→ 231,250 total

10% Owner

Transactions

Conversion
Series C Preferred Stock
2020-04-28−497,809→ 0 total
→ Common Stock (497,809 underlying)
Conversion
Common Stock
2020-04-28+231,250→ 231,250 total
Conversion
Series B Preferred Stock
2020-04-28−2,268,750→ 0 total(indirect: See footnote)
→ Common Stock (2,268,750 underlying)
Conversion
Common Stock
2020-04-28+497,809→ 729,059 total
Conversion
Common Stock
2020-04-28+314,815→ 1,043,874 total
Conversion
Common Stock
2020-04-28+2,268,750→ 2,268,750 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2020-04-28−231,250→ 0 total
→ Common Stock (231,250 underlying)
Conversion
Series D Preferred Stock
2020-04-28−314,815→ 0 total
→ Common Stock (314,815 underlying)

10% Owner

Transactions

Conversion
Common Stock
2020-04-28+231,250→ 231,250 total
Conversion
Common Stock
2020-04-28+314,815→ 1,043,874 total
Conversion
Series B Preferred Stock
2020-04-28−231,250→ 0 total
→ Common Stock (231,250 underlying)
Conversion
Series D Preferred Stock
2020-04-28−314,815→ 0 total
→ Common Stock (314,815 underlying)
Conversion
Common Stock
2020-04-28+497,809→ 729,059 total
Conversion
Common Stock
2020-04-28+2,268,750→ 2,268,750 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2020-04-28−497,809→ 0 total
→ Common Stock (497,809 underlying)
Conversion
Series B Preferred Stock
2020-04-28−2,268,750→ 0 total(indirect: See footnote)
→ Common Stock (2,268,750 underlying)

Footnotes (3)

[F1]Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.
[F2]The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
[F3]The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Documents

1 file

Oric Pharmaceuticals, Inc.

CIK 0001796280

Entity typeother

IncorporatedDE